Enzyme induction by drugs and toxins.

[1]  P. Srivastava,et al.  Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. , 1991, Molecular pharmacology.

[2]  A. Guillouzo,et al.  Evidence for the involvement of several cytochromes P-450 in the first steps of caffeine metabolism by human liver microsomes. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[3]  F. Guengerich,et al.  A comparison of levels of glutathione transferases, cytochromes P450 and acetyltransferases in human livers. , 1991, Biochemical pharmacology.

[4]  G. Siest,et al.  Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures. , 1991, Molecular pharmacology.

[5]  T. Shimada,et al.  Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s. , 1990, The Journal of pharmacology and experimental therapeutics.

[6]  P. Beaune,et al.  Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme. , 1990, European journal of biochemistry.

[7]  P. Beaune,et al.  Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1 , 1990 .

[8]  D. Koop,et al.  Multiple mechanisms in the regulation of ethanol‐inducible cytochrome P450IIE1 , 1990, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  P. Maurel,et al.  Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. , 1990, Gastroenterology.

[10]  C. Bonfils,et al.  Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[11]  G. Siest,et al.  Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3'-azido-3'-deoxythymidine: characterization of the enzyme in human and rat liver microsomes. , 1990, Archives of biochemistry and biophysics.

[12]  S. Kobayashi,et al.  Strain differences of antipyrine, trimethadione, and debrisoquine metabolism in female rats. , 1990, Research communications in chemical pathology and pharmacology.

[13]  C. Omiecinski,et al.  Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. , 1990, Cancer research.

[14]  D. Breimer,et al.  A 'cocktail' strategy to assess in vivo oxidative drug metabolism in humans. , 1990, Trends in pharmacological sciences.

[15]  R. Levy,et al.  Inhibition of epoxide hydrolase by valproic acid in epileptic patients receiving carbamazepine. , 1990, British journal of clinical pharmacology.

[16]  F. Gonzalez,et al.  The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. , 1990, Biochemistry.

[17]  U. Meyer,et al.  Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4 , 1989, Clinical pharmacology and therapeutics.

[18]  P. Beaune,et al.  The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. , 1989, British journal of clinical pharmacology.

[19]  M. Butler,et al.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Siest,et al.  [Variation in the urinary excretion of 6-beta-hydroxycortisol in humans after administration of the new isoquinoline derivative, PK-11195 (52028 RP)]. , 1989, Therapie.

[21]  T. Aoyama,et al.  Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. , 1989, The Journal of biological chemistry.

[22]  C. Lieber,et al.  Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. , 1989, Archives of biochemistry and biophysics.

[23]  P. Watkins,et al.  Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. , 1989, The Journal of clinical investigation.

[24]  D. Breimer,et al.  Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjects. , 1988, Biochemical pharmacology.

[25]  R Joeres,et al.  Influence of smoking on caffeine elimination in healthy volunteers and in patients with alcoholic liver cirrhosis , 1988, Hepatology.

[26]  J. Miners,et al.  Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies. , 1988, Biochemical pharmacology.

[27]  P. Krumbiegel,et al.  [15N]methacetin urine test to measure liver function: methodology for application in pediatrics. , 1988, Journal of pediatric gastroenterology and nutrition.

[28]  K. Bock,et al.  Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers. , 1987, Biochemical pharmacology.

[29]  S. Wrighton,et al.  Purification and characterization of ethanol-inducible human hepatic cytochrome P-450HLj. , 1987, Archives of biochemistry and biophysics.

[30]  F. Gonzalez,et al.  Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat. , 1987, Molecular endocrinology.

[31]  G. Siest,et al.  The glucuronosyltransferases: what progress can pharmacologists expect from molecular biology and cellular enzymology? , 1987, Biochemical pharmacology.

[32]  G. Siest,et al.  Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents. , 1987, Xenobiotica; the fate of foreign compounds in biological systems.

[33]  R. Preisig,et al.  Overnight salivary caffeine clearance: A liver function test suitable for routine use , 1987, Hepatology.

[34]  P. Watkins,et al.  Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. , 1986, Biochemistry.

[35]  G. Siest,et al.  ELISA of 6-beta-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[36]  S. Kobayashi,et al.  Trimethadione tolerance test for evaluation of functional reserve of the liver in patients with liver cirrhosis and esophageal varices. , 1986, Journal of pharmacobio-dynamics.

[37]  H. Jörnvall,et al.  Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Nebert,et al.  Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. , 1985, Nucleic acids research.

[39]  H. Glatt,et al.  Interindividual variations in the activities of cytosolic and microsomal epoxide hydrolase in human liver. , 1985, Carcinogenesis.

[40]  Manchester Dk,et al.  Maternal Smoking Increases Xenobiotic Metabolism in Placenta but Not Umbilical Vein Endothelium , 1984 .

[41]  M. Sclavons,et al.  Use of An Internal Standard To Assay 6 Beta-hydroxycortisol in Urine , 1984 .

[42]  P. Beaune,et al.  Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450. , 1983, British journal of clinical pharmacology.

[43]  B. K. Park,et al.  Assessment of urinary 6 beta-hydroxycortisol as an in vivo index of mixed-function oxygenase activity. , 1981, British journal of clinical pharmacology.

[44]  G. Siest,et al.  Stereochemical heterogeneity of hepatic UDP-glucuronosyltransferase activity in rat liver microsomes. , 1981, Biochemical pharmacology.

[45]  G. Siest,et al.  gamma-Glutamyltransferase of rabbit liver: Kinetic study of phenobarbital induction and in vitro solubilization by bile salts. , 1980, Toxicology and applied pharmacology.

[46]  P. N. Chhuttani,et al.  Hepatic bromsulphthalein-glutathione conjugating enzyme activity in patients with liver disease with particular reference to effects of enzyme inducer. , 1976, The Indian journal of medical research.

[47]  E. Syvälahti,et al.  RIFAMPICIN AND DRUG METABOLISM , 1974 .

[48]  A. Conney.  Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[49]  T. Tephly,et al.  Glucuronidation of monohydroxylated short chain bile acids by human liver microsomes and purified human liver UDP-glucuronosyltransferases. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[50]  G. Siest,et al.  Oral contraceptives stimulate the excretion of clofibric acid glucuronide in women and female rats. , 1991, General pharmacology.

[51]  K. Cowan,et al.  Glutathione S-transferases and drug resistance. , 1990, Cancer cells.

[52]  R. Maronpot,et al.  Regulation of the expression of some genes for enzymes of glutathione metabolism in hepatotoxicity and hepatocarcinogenesis. , 1989, Toxicology and applied pharmacology.

[53]  D W Nebert,et al.  The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. , 1989, Critical reviews in toxicology.

[54]  F. Guengerich.  Characterization of human microsomal cytochrome P-450 enzymes. , 1989, Annual review of pharmacology and toxicology.

[55]  C. Wittekind,et al.  Monoethylglycinexylidide Formation Kinetics: A Novel Approach to Assessment of Liver Function , 1987, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[56]  P. R. Yeager,et al.  A semiautomated procedure for urinary D-glucaric acid using a centrifugal analyzer. , 1986, Journal of analytical toxicology.

[57]  A. Meister,et al.  Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization. , 1976, Annual review of biochemistry.

[58]  A. Emmerson,et al.  Letter: Urinals soaked in disinfectants. , 1975, Lancet.